REGN vs WYNN · P/E 14, rev $4.29B vs P/E 29, rev $3.71B
Regeneron Pharmaceuticals Inc (REGN) versus Wynn Resorts Limited (WYNN) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Wynn Resorts Limited (WYNN) is a resorts & casinos company listed on NASDAQ.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported WYNN revenue for 2026-06-30 was $3.71B. Net income was $260.5M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
Not investment advice. Open the REGN and WYNN stock pages for the full models.
Not investment advice.